These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16890648)

  • 1. Second primary malignancies associated with renal cell carcinoma histological subtypes.
    Thompson RH; Leibovich BC; Cheville JC; Webster WS; Lohse CM; Kwon ED; Zincke H; Blute ML
    J Urol; 2006 Sep; 176(3):900-3; discussion 903-4. PubMed ID: 16890648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in organ system of distant metastasis by renal cell carcinoma subtype.
    Hoffmann NE; Gillett MD; Cheville JC; Lohse CM; Leibovich BC; Blute ML
    J Urol; 2008 Feb; 179(2):474-7. PubMed ID: 18076920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma.
    Leibovich BC; Lohse CM; Crispen PL; Boorjian SA; Thompson RH; Blute ML; Cheville JC
    J Urol; 2010 Apr; 183(4):1309-15. PubMed ID: 20171681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden.
    Czene K; Hemminki K
    J Urol; 2003 Apr; 169(4):1271-5. PubMed ID: 12629341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple primary malignancies in renal cell carcinoma.
    Rabbani F; Grimaldi G; Russo P
    J Urol; 1998 Oct; 160(4):1255-9. PubMed ID: 9751330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients.
    Bani-Hani AH; Leibovich BC; Lohse CM; Cheville JC; Zincke H; Blute ML
    J Urol; 2005 Feb; 173(2):391-4. PubMed ID: 15643178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification.
    Skolarus TA; Serrano MF; Berger DA; Bullock TL; Yan Y; Humphrey PA; Kibel AS
    J Urol; 2008 Feb; 179(2):439-43; discussion 443-4. PubMed ID: 18076932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
    Lughezzani G; Jeldres C; Isbarn H; Perrotte P; Shariat SF; Sun M; Widmer H; Arjane P; Peloquin F; Pharand D; Patard JJ; Graefen M; Montorsi F; Karakiewicz PI
    J Urol; 2009 Oct; 182(4):1287-93. PubMed ID: 19683281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small renal tumors: correlation of clinical and pathological features with tumor size.
    Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
    J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study.
    Capitanio U; Cloutier V; Zini L; Isbarn H; Jeldres C; Shariat SF; Perrotte P; Antebi E; Patard JJ; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Jun; 103(11):1496-500. PubMed ID: 19076149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of tumour location on the histological subtype of renal cortical tumours.
    Schachter LR; Bach AM; Snyder ME; Kattan MW; Russo P
    BJU Int; 2006 Jul; 98(1):63-6. PubMed ID: 16831144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients.
    Nishikubo CY; Kunkel LA; Figlin R; Belldegrun A; Rosen P; Elashoff R; Wang H; Territo MC
    Cancer; 1996 Dec; 78(11):2421-6. PubMed ID: 8941014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Analysis of Smoking as a Risk Factor among Renal Cell Carcinoma Histological Subtypes.
    Patel NH; Attwood KM; Hanzly M; Creighton TT; Mehedint DC; Schwaab T; Kauffman EC
    J Urol; 2015 Sep; 194(3):640-6. PubMed ID: 25896558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
    Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
    J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis.
    Barocas DA; Rohan SM; Kao J; Gurevich RD; Del Pizzo JJ; Vaughan ED; Akhtar M; Chen YT; Scherr DS
    J Urol; 2006 Nov; 176(5):1957-62. PubMed ID: 17070218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
    Klatte T; Wunderlich H; Patard JJ; Kleid MD; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
    BJU Int; 2007 Jul; 100(1):21-5. PubMed ID: 17433034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.